PTGS2 and hyperinsulinemic hypoglycemia, familial, 4: Sapropterin is a drug used in the treatment of tetrahydrobiopterin (BH4) deficiency through its specific inhibition of PTGS2; however, it is not used for the treatment of any specific type of cancer.